Laboratorios Osorio de Moraes Ltda.   Report issue

For profit Phase 3
Founded: Contagem Brazil (1911)
Status: No NME R&D (1911)

Organization Overview

First Clinical Trial
2009
NCT00967317
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dysuria (Phase 3)

Otitis (Phase 3)

Otitis Externa (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6